ERBB2 and breast cancer: Colocalization analysis suggested that fasting and 2-h GIP concentrations had a >99.9% posterior probability of sharing a causal variant with both overall and luminal A-like breast cancer risk within the GIPR locus and a >51.8% probability of sharing a causal variant with luminal B HER2 negative-like breast cancer (Table 2).